1. Home
  2. FOX vs UTHR Comparison

FOX vs UTHR Comparison

Compare FOX & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Corporation Class B

FOX

Fox Corporation Class B

HOLD

Current Price

$57.94

Market Cap

25.1B

Sector

Industrials

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$587.65

Market Cap

23.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOX
UTHR
Founded
2018
1996
Country
United States
United States
Employees
10550
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.1B
23.1B
IPO Year
2018
1999

Fundamental Metrics

Financial Performance
Metric
FOX
UTHR
Price
$57.94
$587.65
Analyst Decision
Buy
Buy
Analyst Count
3
15
Target Price
$76.50
★ $661.29
AVG Volume (30 Days)
674.1K
★ 682.9K
Earning Date
11-02-2026
11-04-2026
Dividend Yield
★ 0.96%
N/A
EPS Growth
N/A
★ 13.07
EPS
3.84
★ 13.07
Revenue
★ $14,913,000,000.00
$1,483,300,000.00
Revenue This Year
$3.28
$0.15
Revenue Next Year
N/A
$13.57
P/E Ratio
★ $15.49
$44.91
Revenue Growth
★ 6.72
2.38
52 Week Low
$44.08
$409.15
52 Week High
$68.18
$609.35

Technical Indicators

Market Signals
Indicator
FOX
UTHR
Relative Strength Index (RSI) 51.22 68.74
Support Level $56.37 $525.83
Resistance Level $62.13 $586.61
Average True Range (ATR) 1.55 17.76
MACD 0.35 4.45
Stochastic Oscillator 53.65 91.10

Price Performance

Historical Comparison
FOX
UTHR

About FOX Fox Corporation Class B

Fox operates in two segments: cable networks and television. Cable networks primarily includes Fox News, Fox Business, and several pay-TV sports stations. Television primarily includes the Fox broadcast network, 29 owned and operated local television stations, of which 18 are affiliated with the Fox network, and streaming platform Tubi, which is not subscription-based and is completely ad-supported. Fox effectively sold most of its entertainment assets to Disney in 2019, so it no longer creates entertainment content and relies heavily on live news and sports, with nearly all tied to the pay-TV bundle. The Murdoch family controls Fox.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: